Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Japan
Japan
Aslan sells Japanese rights to would-be Dupixent rival for $12M
Fierce Biotech
Thu, 06/22/23 - 10:41 pm
Aslan
Dupixent
Japan
eczema
Sanofi
Regeneron
eblasakimab
With skin in the game, Satsuma's partner offers buyout to get migraine spray to market
Fierce Biotech
Mon, 04/17/23 - 12:07 pm
Satsuma Pharmaceuticals
Japan
migraines
Shin Nippon Biomedical
M&A
Takeda invests $760M+ into new plasma-derived therapy manufacturing site in Japan
Endpoints
Thu, 03/23/23 - 08:54 pm
Takeda
Japan
plasma therapy
drug manufacturing
Japan cancels 140M dose order for Novavax Covid vaccine amid 'lower than expected' demand
Endpoints
Sun, 02/12/23 - 07:44 pm
Japan
Novavax
COVID-19
vaccines
Takeda
Daiichi Sankyo to build Japan's first mRNA vaccine manufacturing facility — report
Endpoints
Wed, 02/8/23 - 10:58 pm
Daiichi Sankyo
Japan
MRNA
vaccines
drug manufacturing
Moderna makes its first-ever acquisition, buying Japanese DNA manufacturer OriCiro for $85M
Fierce Pharma
Wed, 01/4/23 - 10:21 am
Moderna Therapeutics
M&A
DNA
Japan
OriCiro Genomics
Daiichi Sankyo To Transfer Yescarta Marketing Authorization In Japan To Gilead Sciences
NASDAQ.com
Thu, 12/8/22 - 10:03 am
Daiichi Sankyo
Gilead Sciences
Yescarta
Japan
Shionogi's COVID-19 antiviral nabs Japanese approval to rival drugs from Pfizer, Merck
Fierce Pharma
Tue, 11/22/22 - 04:28 pm
Shionogi
COVID-19
antivirals
Japan
Medtronic's Hugo Clears 3 Major Regulatory Hurdles
Medical Devices and Diagnostics Industry
Thu, 10/20/22 - 10:28 am
Medtronic
devices
robotic surgery
Medtech
Europe
Japan
Canada
Ocugen sniffs out COVID-19 vaccine opportunity, landing rights to nasal candidate with India authorization
Fierce Pharma
Tue, 10/4/22 - 10:42 am
Ocugen
vaccines
COVID-19
intranasal vaccines
Europe
Japan
India
Daiichi Sankyo's Ezharmia Becomes First EZH1/2 Inhibitor for Blood Cancer
BioSpace
Mon, 09/26/22 - 11:32 pm
Daiichi Sankyo
Japan
Ezharmia
relapsed or refractory adult T-cell leukemia/lymphoma
AstraZeneca's Evusheld nabs its first global nod as a COVID treatment
Fierce Pharma
Wed, 08/31/22 - 10:34 pm
AstraZeneca
Evusheld
COVID-19
Japan
Moderna and Takeda Announce Plans to Transfer Marketing Authorization for Spikevax(TM) COVID-19 Vaccine in Japan to Moderna
BioSpace
Tue, 05/31/22 - 10:32 am
Moderna Therapeutics
Takeda
Japan
vaccines
COVID-19
Sanofi's Xenpozyme gets approval in Japan for rare genetic disease
Seeking Alpha
Mon, 03/28/22 - 10:30 am
Sanofi
Xenpozyme
Japan
ASMD
Shionogi's COVID-19 vaccine matches Pfizer's Comirnaty in booster trial
Fierce Biotech
Fri, 03/4/22 - 09:46 am
Shionogi
vaccines
COVID-19
Japan
Pfizer
Shionogi files for approval of oral COVID-19 antiviral in Japan, brushing off missed clinical endpoint in race to market
Fierce Biotech
Mon, 02/28/22 - 11:19 am
Shionogi
Japan
antivirals
COVID-19
Amgen Snags Another Approval for This Promising Cancer Drug
Motley Fool
Wed, 02/16/22 - 10:48 am
Amgen
Japan
Lumakras
non-small cell lung cancer
advanced non-small cell lung cancer
Daiichi makes play for share of Japan’s COVID booster market
Pharmaforum
Mon, 01/31/22 - 10:49 am
Daiichi Sankyo
COVID-19
vaccines
MRNA
Japan
DS-5670
Biogen, Eisai face down another Aduhelm refusal—this time from Japanese regulators
Fierce Pharma
Wed, 12/22/21 - 11:06 am
Biogen
Eisai
Aduhelm
Japan
Alzheimer's disease
Merck inks yet another $1B-plus supply deal for COVID pill, this time with Japan
Fierce Pharma
Wed, 11/10/21 - 09:32 pm
Merck
COVID-19
molnupiravir
Japan
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »